Successful Treatment of Disseminated Nocardiosis Caused by Nocardia veterana in a Dog

J Vet Intern Med. 2018 Jan;32(1):418-422. doi: 10.1111/jvim.14855. Epub 2017 Nov 4.

Abstract

A 5-year-old male castrated Lhasa Apso cross was evaluated for a 1-month history of inappetence, lethargy, gagging, and progressive right thoracic limb lameness. Synovial fluid analysis revealed nonseptic suppurative inflammation, and a diagnosis of immune-mediated polyarthritis (IMPA) was made. After 3 months of treatment with prednisone and later cyclosporine, the dog developed multiple firm cutaneous and subcutaneous masses and a focal mass within the jejunum. Cultures of blood, urine, skin lesions, and the jejunal mass identified Nocardia veterana by matrix-absorption laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) and allowed for earlier identification of the organism compared to more traditional secA1 gene sequencing. Immunosuppressive drug treatment was discontinued, and the dog was treated for 3 months by administration of trimethoprim-sulfamethoxazole (TMS). No recurrence of clinical signs was reported 1 year later. This case report highlights the clinical utility of MALDI-TOF MS, particularly for the rapid identification of slow-growing, fastidious organisms.

Keywords: Actinomycetales; Antimicrobial treatment; Bacteremia; Immunosuppression; MALDI-TOF MS.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Arthritis / drug therapy
  • Arthritis / immunology
  • Arthritis / veterinary
  • Cyclosporine / therapeutic use
  • Dog Diseases / drug therapy
  • Dog Diseases / microbiology
  • Dogs
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Nocardia / isolation & purification*
  • Nocardia Infections / diagnosis
  • Nocardia Infections / drug therapy
  • Nocardia Infections / veterinary*
  • Prednisone / therapeutic use
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / veterinary
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Cyclosporine
  • Prednisone